SCHEMBL11278256

SCHEMBL11278256

CN1CN2C=CC=CC2=N1

nearest known ligand 0.37

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
POLB P06746 1/20 0.37
HSD17B10 Q99714 1/20 0.37
MEN1 O00255 1/20 0.30
MAPT P10636 1/20 0.30
CASP1 P29466 1/20 0.30
CASP7 P55210 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21142466 0.75 KDM4E (0.34) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL3457997 0.64 KDM4E (0.38) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL4570765 0.61 KDM4E (0.47) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL870972 0.61
SCHEMBL15057332 0.61
SCHEMBL19262448 0.60 KDM4E (0.35) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL2799195 0.60
SCHEMBL892819 0.60 ALDH1A1 (0.38) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL13898394 0.60
SCHEMBL7146308 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed
US-4358454-A ANTIULCER AGENT SCHERING CORPORATION (US) 1982-11-09 US disclosed